Academic
Publications
Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines,10.1007/s12094-011-0694-x,Clinical & Translational Oncology,Jaime Feliu,Javier S

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines  
BibTex | RIS | RefWorks Download
While hepatocellular carcinoma (HCC) is a relatively common tumour with an annual incidence in the EU of 8 cases/100,000 inhabitants, bile tract carcinoma (BTC) is much less common, with an incidence of 4 cases per 100,000 inhabitants per year. In both cases, when planning treatment it is essential to perform accurate staging, evaluate hepatic functional reserve and performance status, and obtain the opinion of the patient. The only curative treatment is surgery. However, several interventional radiological techniques can help to achieve local disease control and the alleviation of symptoms. In addition, sorafenib (HCC) and chemotherapy (BTC) may contribute to prolong survival in patients with disseminated disease. Therefore, the therapeutic strategy should always be discussed and planned within a multidisciplinary tumour board.
Journal: Clinical & Translational Oncology - CLIN TRANSL ONCOL , vol. 13, no. 8, pp. 536-544, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.